MLYS
Price
$13.71
Change
-$0.29 (-2.07%)
Updated
Jun 27 closing price
Capitalization
893.55M
42 days until earnings call
PTGX
Price
$55.69
Change
+$0.47 (+0.85%)
Updated
Jun 27 closing price
Capitalization
3.45B
31 days until earnings call
Interact to see
Advertisement

MLYS vs PTGX

Header iconMLYS vs PTGX Comparison
Open Charts MLYS vs PTGXBanner chart's image
Mineralys Therapeutics
Price$13.71
Change-$0.29 (-2.07%)
Volume$2.23M
Capitalization893.55M
Protagonist Therapeutics
Price$55.69
Change+$0.47 (+0.85%)
Volume$1.55M
Capitalization3.45B
MLYS vs PTGX Comparison Chart in %
Loading...
MLYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MLYS vs. PTGX commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLYS is a Buy and PTGX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (MLYS: $13.71 vs. PTGX: $55.69)
Brand notoriety: MLYS and PTGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLYS: 268% vs. PTGX: 172%
Market capitalization -- MLYS: $893.55M vs. PTGX: $3.45B
MLYS [@Biotechnology] is valued at $893.55M. PTGX’s [@Biotechnology] market capitalization is $3.45B. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLYS’s FA Score shows that 0 FA rating(s) are green whilePTGX’s FA Score has 1 green FA rating(s).

  • MLYS’s FA Score: 0 green, 5 red.
  • PTGX’s FA Score: 1 green, 4 red.
According to our system of comparison, PTGX is a better buy in the long-term than MLYS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLYS’s TA Score shows that 3 TA indicator(s) are bullish while PTGX’s TA Score has 5 bullish TA indicator(s).

  • MLYS’s TA Score: 3 bullish, 6 bearish.
  • PTGX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, PTGX is a better buy in the short-term than MLYS.

Price Growth

MLYS (@Biotechnology) experienced а +1.71% price change this week, while PTGX (@Biotechnology) price change was +4.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

MLYS is expected to report earnings on Aug 11, 2025.

PTGX is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PTGX($3.45B) has a higher market cap than MLYS($894M). PTGX YTD gains are higher at: 44.275 vs. MLYS (11.373). PTGX has higher annual earnings (EBITDA): 30.1M vs. MLYS (-201.44M). PTGX has more cash in the bank: 574M vs. MLYS (343M). PTGX has higher revenues than MLYS: PTGX (208M) vs MLYS (0).
MLYSPTGXMLYS / PTGX
Capitalization894M3.45B26%
EBITDA-201.44M30.1M-669%
Gain YTD11.37344.27526%
P/E RatioN/A71.40-
Revenue0208M-
Total Cash343M574M60%
Total DebtN/A11.4M-
FUNDAMENTALS RATINGS
PTGX: Fundamental Ratings
PTGX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
44
SMR RATING
1..100
55
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MLYSPTGX
RSI
ODDS (%)
Bullish Trend 3 days ago
63%
Bearish Trend 3 days ago
64%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
78%
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
N/A
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 10 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
73%
Aroon
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
MLYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LGGAX69.130.67
+0.98%
ClearBridge International Growth A
AWSYX16.790.12
+0.72%
Invesco Global Core Equity Y
GWILX15.680.07
+0.45%
Glenmede Women in Leadership US Eq
GACIX45.650.19
+0.42%
Gabelli Small Cap Growth I
BGLYX14.23N/A
N/A
Brookfield Global Listed InfrastructureI

MLYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLYS has been loosely correlated with PTGX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if MLYS jumps, then PTGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLYS
1D Price
Change %
MLYS100%
-2.07%
PTGX - MLYS
51%
Loosely correlated
+0.86%
BIESF - MLYS
45%
Loosely correlated
N/A
XERS - MLYS
37%
Loosely correlated
-0.84%
CRNX - MLYS
36%
Loosely correlated
-0.10%
ACLX - MLYS
36%
Loosely correlated
+0.90%
More

PTGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PTGX has been closely correlated with BIESF. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if PTGX jumps, then BIESF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTGX
1D Price
Change %
PTGX100%
+0.86%
BIESF - PTGX
67%
Closely correlated
N/A
MLYS - PTGX
51%
Loosely correlated
-2.07%
TRVI - PTGX
44%
Loosely correlated
-0.71%
FULC - PTGX
38%
Loosely correlated
-3.79%
MDGL - PTGX
35%
Loosely correlated
N/A
More